Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
General Dynamics
GD
|
+$58M |
| 2 |
Wells Fargo
WFC
|
+$39.8M |
| 3 |
Northrop Grumman
NOC
|
+$39.6M |
| 4 |
Pfizer
PFE
|
+$37.2M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$33.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$59.8M |
| 2 |
Cigna
CI
|
+$42M |
| 3 |
Altria Group
MO
|
+$28.5M |
| 4 |
Philip Morris
PM
|
+$28.3M |
| 5 |
Parker-Hannifin
PH
|
+$26.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.79% |
| 2 | Industrials | 18.96% |
| 3 | Consumer Discretionary | 15.28% |
| 4 | Healthcare | 13.64% |
| 5 | Consumer Staples | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SFLY
326
DELISTED
Shutterfly, Inc.
SFLY
| $5.48M | 0.08% |
+134,806
| New | +$5.92M |
|
327
AGCO
AGCO
$7.48B
| $5.43M | 0.08% |
78,047
+28,118
| +56% | +$1.82M |
|
328
Fair Isaac
FICO
$25.3B
| $5.41M | 0.08% |
19,922
-16,272
| -45% | -$3.82M |
|
|
HI
329
DELISTED
Hillenbrand
HI
| $5.34M | 0.08% |
128,484
-53,900
| -30% | -$2.28M |
|
330
Crocs
CROX
$5.85B
| $5.33M | 0.08% |
206,933
-131,410
| -39% | -$3.6M |
|
|
COHR
331
DELISTED
Coherent Inc
COHR
| $5.3M | 0.08% |
37,421
-62,841
| -63% | -$7.96M |
|
332
Nexstar Media Group
NXST
$5.73B
| $5.29M | 0.08% |
48,844
+32,461
| +198% | +$2.99M |
|
|
VRS
333
DELISTED
Verso Corporation
VRS
| $5.29M | 0.08% |
247,021
+19,293
| +8% | +$445K |
|
334
Baxter International
BAX
$13.6B
| $5.29M | 0.08% |
65,025
-17,179
| -21% | -$1.25M |
|
335
CBRE Group
CBRE
$44B
| $5.28M | 0.08% |
+106,749
| New | +$5.01M |
|
|
WBT
336
DELISTED
Welbilt, Inc.
WBT
| $5.23M | 0.08% |
+319,377
| New | +$4.66M |
|
337
Franklin Templeton
BEN
$17.4B
| $5.21M | 0.08% |
157,155
-8,181
| -5% | -$258K |
|
|
AYX
338
DELISTED
Alteryx Inc
AYX
| $5.19M | 0.08% |
+61,894
| New | +$4.47M |
|
|
PRAH
339
DELISTED
PRA Health Sciences, Inc.
PRAH
| $5.13M | 0.08% |
46,473
-16,970
| -27% | -$1.77M |
|
340
Nasdaq
NDAQ
$54.9B
| $5.1M | 0.07% |
174,933
+146,004
| +505% | +$4.16M |
|
341
Ross Stores
ROST
$76.7B
| $5.1M | 0.07% |
54,781
-49,746
| -48% | -$4.56M |
|
342
Blackbaud
BLKB
$2.16B
| $5.02M | 0.07% |
62,917
-1,314
| -2% | -$96.4K |
|
343
Packaging Corp of America
PKG
$22.5B
| $4.93M | 0.07% |
49,630
-12,294
| -20% | -$1.17M |
|
344
Ziff Davis
ZD
$1.92B
| $4.92M | 0.07% |
65,313
-1,640
| -2% | -$113K |
|
|
MDRX
345
DELISTED
Veradigm Inc. Common Stock
MDRX
| $4.91M | 0.07% |
+514,309
| New | +$5.68M |
|
346
Murphy USA
MUSA
$10.5B
| $4.89M | 0.07% |
57,137
+50,770
| +797% | +$4.01M |
|
|
BBBY
347
DELISTED
Bed Bath & Beyond Inc
BBBY
| $4.88M | 0.07% |
287,460
-485,791
| -63% | -$7.34M |
|
|
K
348
DELISTED
Kellanova
K
| $4.8M | 0.07% |
89,082
-68,986
| -44% | -$3.68M |
|
349
ArcBest
ARCB
$3.14B
| $4.79M | 0.07% |
155,583
+29,107
| +23% | +$1.05M |
|
|
I
350
DELISTED
INTELSAT S. A.
I
| $4.77M | 0.07% |
304,378
+144,879
| +91% | +$3.07M |
|
Similar funds
Joel Greenblatt's Q1 2019 Portfolio in Review
As of Q1 2019, Joel Greenblatt held 1,284 positions worth $6.83B, up 6.1% from $6.44B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Joel Greenblatt withdrew a net $437M in Q1 2019, closing 124 positions and reducing 485 holdings. Its most notable exit was Cigna, an estimated $42M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Joel Greenblatt opened a new position in General Dynamics worth $58.2M.
- Joel Greenblatt's largest Q1 2019 buy was General Dynamics: 343,980 shares worth $58.2M.
- Joel Greenblatt added most to Wells Fargo in Q1 2019, an estimated $39.8M increase.
- Joel Greenblatt's biggest Q1 2019 reduction was RTX Corp, cutting an estimated $59.8M.
- Joel Greenblatt fully exited Cigna in Q1 2019, selling an estimated $42M.
- Joel Greenblatt's ten largest holdings make up 10% of its $6.83B portfolio in Q1 2019.
- Joel Greenblatt opened 319 new positions and closed 124 in Q1 2019.
- Joel Greenblatt's portfolio value rose 6.1% quarter-over-quarter to $6.83B.
Based on Gotham Asset Management's 13F filing for Q1 2019, filed 15 May 2019.